During the past decade, Tianjin Eye Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 3 clinical trials were completed, i.e. on average, 9.4% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tianjin Eye Hospital" #1 sponsor was "Tianjin Eye Hospital" with 16 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Allergan" with 2 trials sponsored, "Chengdu Kanghong Biotech Co., Ltd." with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tianjin Eye Hospital" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Alexandria University" with 1 trials as a collaborator, "Belgian Ocular Laser Centre" with 1 trials as a collaborator, "Gansu Provincial Hospital" with 1 trials as a collaborator and "Health Science Center of Xi'an Jiaotong University" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Tianjin Eye Hospital" are "Myopia" (10 trials), "Macular Edema" (5 trials), "Branch Retinal Vein Occlusion" (3 trials), "Myopia, Progressive" (3 trials) and "Central Retinal Vein Occlusion" (2 trials). Many other conditions were trialed in "Tianjin Eye Hospital" in a lesser frequency.

Most popular intervention types in "Tianjin Eye Hospital" are "Drug" (14 trials), "Device" (8 trials), "Other" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (4 trials), "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Single vision lens" (2 trials) and "+2D PDL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tianjin Eye Hospital" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Tianjin Eye Hospital". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Tianjin Eye Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tianjin Eye Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".